Varubi issues??

Discussion in 'Tesaro' started by anonymous, Jan 10, 2018 at 8:31 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Heard some concern about Varubi side effects and possible real issues. Maybe even pt death while on Varubi.

    Can anyone in sales confirm? Hope it’s not true.
     

  2. anonymous

    anonymous Guest

    Sadly heard of 1 death attributed to Varubi through a friend in company. Not sure if there’s been others reported yet or not.
     
  3. anonymous

    anonymous Guest

    What would be the pharmacological reason. Doesnt seem plausible.
     
  4. anonymous

    anonymous Guest

    Multiple reports of hypersensitivity. Trouble
     
  5. anonymous

    anonymous Guest

    Anyone seen marketing strategy to address?
     
  6. anonymous

    anonymous Guest

    You nailed that one. anaphylactic shock is never good.
     
  7. anonymous

    anonymous Guest

    All NK-1 antagonists carry the same anaphylaxis warning, no worries.
     
  8. anonymous

    anonymous Guest

    No worries huh? Let’s see...Varubi is under performing so this certainly isn’t going to help. Second Zejula is losing share weekly, lastly the stock...plenty to worry about.
     
  9. anonymous

    anonymous Guest

    Yes I agree if you aren’t concern then you are either stupid or in denial!
     
  10. anonymous

    anonymous Guest

    Now you are just a me too drug as you lost your advantage!
     
  11. anonymous

    anonymous Guest

    If you were selling based on an "anaphylaxis" warning on Emend that explains a lot.